Nicola P Klein et al,Surveillance for Adverse Events After COVID-19 mRNA Vaccination,JAMA .2021 Oct 12;326(14):1390-1399.
Miguel García-Grimshaw et al,Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study,Clin Immunol . 2021 Aug;229:108786.
Jae Hyoung Im etal,Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers,Yonsei Med J . 2021 Dec;62(12):1162-1168.
Riad A, Pokorná A,Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med2021;10:1428
Giancarlo Ripabelli et al,Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech,Comirnaty): A Cross-Sectional Study,J Community Health. 2021 Oct 9;1-15
Mohamad-Gabriel Alameh et al, Messenger RNA-Based Vaccines Against Infectious Diseases, CurrTop Microbiol Immunol 2020 Apr 17. doi: 10.1007/82_2020_202.
Pardi, N., Hogan,M.J., Naradikian, M.S., Parkhouse, K., Cain, D.W., Jones, L., Moody, M.A.,Verkerke, H.P., Myles, A., Willis, E., et al. (2018a). Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.J. Exp. Med. 215, 1571– 1588
Ndeupen, S., Qin, Z., Jacobsen, S., Bouteau, A., Estanbouli, H.,Igyártó, B.Z., The mRNA-LNP platform’s lipid nanoparticle component used inpreclinical vaccine studies is highly inflammatory, ISCIENCE (2021),